Growth Metrics

Pacific Biosciences Of California (PACB) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.39%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.38%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 6.53%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 54.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 54.53%
Dec 31, 2025 21.79%
Sep 30, 2025 20.97%
Jun 30, 2025 16.26%
Mar 31, 2025 -73.56%
Dec 31, 2024 26.71%
Jun 30, 2024 -61.69%
Mar 31, 2024 3.66%
Dec 31, 2023 -45.72%
Sep 30, 2023 -41.29%
Jun 30, 2023 -44.62%
Mar 31, 2023 -315.52%
Dec 31, 2022 -875.15%
Sep 30, 2022 -38.26%
Jun 30, 2022 -42.65%
Mar 31, 2022 -39.03%
Dec 31, 2021 -31.06%
Jun 30, 2021 -22.07%
Mar 31, 2021 -53.49%
Dec 31, 2020 77.68%
Sep 30, 2020 -2.49%
Jun 30, 2020 3.31%
Mar 31, 2020 27.09%
Dec 31, 2019 83.15%
Sep 30, 2019 -18.52%
Jun 30, 2019 -9.96%
Mar 31, 2019 -16.15%
Dec 31, 2018 -179.60%
Sep 30, 2018 -150.68%
Jun 30, 2018 -23.61%
Mar 31, 2018 -6.22%
Dec 31, 2017 -3.05%
Sep 30, 2017 -33.95%
Jun 30, 2017 -10.10%
Mar 31, 2017 -8.11%
Dec 31, 2016 -3.37%
Sep 30, 2016 5.13%
Jun 30, 2016 3.32%
Mar 31, 2016 2.85%
Dec 31, 2015 59.79%
Sep 30, 2015 27.65%
Jun 30, 2015 19.04%
Mar 31, 2015 9.90%
Dec 31, 2014 5.97%
Sep 30, 2014 32.11%
Jun 30, 2014 5.48%
Mar 31, 2014 18.44%
Dec 31, 2013 22.15%
Sep 30, 2013 20.45%
Jun 30, 2013 14.47%